Show simple item record

dc.contributor.authorOchieng, PO
dc.contributor.authorMcLigeyo, SO
dc.contributor.authorAmayo, EO
dc.contributor.authorKayima, JK
dc.contributor.authorOmonge, EO
dc.date.accessioned2013-02-19T14:17:11Z
dc.date.issued2009
dc.identifier.citationEast African Medical Journalen
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10349
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/21644414
dc.description.abstractObjectives: To describe the incidence of renal dysfunction, hypokalaemia and hypomagnesaemia in AIDS patients with cryptococcal meningitis and on amphotericin B treatment. Secondary objective was to determine all-cause mortality in the same group. Design: Prospective, observational study. Setting: Kenyatta National Hospital (KNH), Nairobi, Kenya. Subjects: Seventy consecutive patients with AIDS and cryptococcal meningitis on amphotericin B. Results: About 58.6% of the patients had at least 100% rise in the creatinine level. Thirty eight point six per cent of patients experienced a rise in serum creatinine of at least 50%. Ninty three per cent of the patients developed hypokalaemia and 80% had hypomagnesaemia at trough magnesium level. Only 54.3% of patients completed the intended 14-day treatment. Thirty point five per cent of patients died within the two week follow-up period. Conclussion: The incidences of amphotericin B associated nephrotoxicity, hypokalemia and hypomagnesaemia were high in this studied population.en
dc.language.isoenen
dc.relation.ispartofseriesVol. 86 No.9;
dc.titleNephrotoxicity of amphotericin b in the treatment of cryptococcal meningitis in acquired immunodeficiency syndrome patientsen
dc.typeArticleen
local.publisherDepartment of Clinical Medicine and Therapeutics, College of Health Sciences, University of Nairobien


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record